Shots: With the implementation of the Inflation Reduction Act (IRA) in 2022, several pricing reforms were introduced, including the new mandated drug pricing and discount elements Today, we have with us Gavin Magaha, Senior Director, Value Delivery for Kalderos, shedding light on the challenges that come with the IRA act and the impact it puts on…
Shots:Know Your Investor’s November Edition revolves around Alexandria Venture Investments, which dedicatedly invests in the healthcare sector Established in 1996, Alexandria Venture Investments is based in Pasadena, California, and is the corporate venture capital arm of Alexandria Real Estate EquitiesIn 2022, Alexandria participated in 31 investment rounds, with Affini-T Therapeutics receiving the highest…
Shots:Thank you for believing in us. We promise to always provide our readers with the excellent service that they can utilize to support and grow their businessWe would like to announce our bespoke service which is a dedicated customized news alert service for you and your team, specific to any therapy area and…
The US FDA has approved 3 NDAs and 2 BLAs in Jan 2022, leading to treatments for patients and advances in the health care industry. The CDER and CBER approved 5 novel products in 2022In Jan 2022, the major highlights were Quviviq's approval for insomnia, Cibinqo for atopic dermatitis, Kimmtrak for unresectable or metastatic…

